• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.

作者信息

Lippi Giuseppe, Plebani Mario

机构信息

Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy.

Department of Laboratory Medicine, University Hospital of Padova, Padova, Italy.

出版信息

Clin Chim Acta. 2020 Jun;505:190-191. doi: 10.1016/j.cca.2020.03.004. Epub 2020 Mar 4.

DOI:10.1016/j.cca.2020.03.004
PMID:32145275
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7094472/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8286/7094472/04646e0e274d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8286/7094472/04646e0e274d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8286/7094472/04646e0e274d/gr1_lrg.jpg

相似文献

1
Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.2019年冠状病毒病（COVID-19）重症患者的降钙素原：一项荟萃分析。
Clin Chim Acta. 2020 Jun;505:190-191. doi: 10.1016/j.cca.2020.03.004. Epub 2020 Mar 4.
2
Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care unit.降钙素原作为重症监护病房中新冠肺炎患者抗生素管理工具的应用
J Glob Antimicrob Resist. 2020 Sep;22:782-784. doi: 10.1016/j.jgar.2020.07.017. Epub 2020 Jul 25.
3
The Role of Chest Radiograph, Procalcitonin and Moxifloxacin in Diagnosis and Management of Breast Cancer Patients with COVID-19.胸部X光片、降钙素原及莫西沙星在乳腺癌合并新型冠状病毒肺炎患者诊断与治疗中的作用
Acta Med Indones. 2020 Apr;52(2):163-171.
4
Covid-19 antibody tests: a briefing.新冠病毒-19抗体检测：简报
BMJ. 2020 Jun 24;369:m2284. doi: 10.1136/bmj.m2284.
5
Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients.新型冠状病毒特异性 IgA 反应在 COVID-19 患者中的特征。
Eur Respir J. 2020 Aug 27;56(2). doi: 10.1183/13993003.01526-2020. Print 2020 Aug.
6
[Forhøjet D-dimer og karakteristiske billeddiagnostiske fund hos patient med COVID-19].[新冠病毒病患者D-二聚体升高及特征性影像学表现]
Ugeskr Laeger. 2020 Jun 8;182(24).
7
High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies.用于检测IgG抗SARS-CoV-2抗体的Liaison SARS-CoV-2商业化学发光微粒免疫分析在非COVID-19急性感染患者中假阳性结果的高发生率
J Clin Microbiol. 2020 Oct 21;58(11). doi: 10.1128/JCM.01352-20.
8
What to Expect from Antibody Assays of SARS-CoV-2?对新型冠状病毒2019（SARS-CoV-2）抗体检测有何期待？
J Appl Lab Med. 2020 Sep 1;5(5):1126-1130. doi: 10.1093/jalm/jfaa100.
9
A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.一名严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体多次检测不到的新型冠状病毒肺炎（COVID-19）患者。
J Appl Lab Med. 2020 Nov 1;5(6):1401-1405. doi: 10.1093/jalm/jfaa137.
10
The Promise and Peril of Antibody Testing for COVID-19.新冠病毒抗体检测的前景与风险
JAMA. 2020 May 19;323(19):1881-1883. doi: 10.1001/jama.2020.6170.

引用本文的文献

1
The prognostic values of monitoring changes in coagulative, inflammatory, and blood chemistry markers in COVID-19 patient's before and during admission to ICU: a retrospective cohort study.监测COVID-19患者在入住重症监护病房前后凝血、炎症和血液化学标志物变化的预后价值：一项回顾性队列研究。
Ann Med Surg (Lond). 2025 Jul 22;87(9):5401-5408. doi: 10.1097/MS9.0000000000003600. eCollection 2025 Sep.
2
Assessment of smoking exposure by urine cotinine levels in severe COVID-19 patients: a case-control study.通过尿可替宁水平评估重症 COVID-19 患者的吸烟暴露情况：一项病例对照研究。
Sci Rep. 2025 Aug 28;15(1):31696. doi: 10.1038/s41598-025-17768-7.
3

本文引用的文献

1
Which lessons shall we learn from the 2019 novel coronavirus outbreak?我们应从2019年新型冠状病毒疫情中学到哪些教训？
Ann Transl Med. 2020 Feb;8(3):48. doi: 10.21037/atm.2020.02.06.
2
Laboratory abnormalities in patients with COVID-2019 infection.2019冠状病毒病感染患者的实验室异常情况。
Clin Chem Lab Med. 2020 Jun 25;58(7):1131-1134. doi: 10.1515/cclm-2020-0198.
3
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
Endothelin-1 in combination with CRB-65 enhance risk stratification in COVID-19 patients.
内皮素-1与CRB-65联合使用可改善新冠病毒肺炎患者的风险分层。
Infection. 2025 Aug 19. doi: 10.1007/s15010-025-02627-4.
4
Differences in the inflammatory response and outcome among hospitalized patients during different waves of the COVID-19 pandemic.新冠疫情不同波次期间住院患者炎症反应及预后的差异。
Front Immunol. 2025 Mar 27;16:1545181. doi: 10.3389/fimmu.2025.1545181. eCollection 2025.
5
Persistently high plasma procalcitonin levels despite successful treatment of tuberculous pleuritis and tuberculous lymphadenitis patients.尽管结核性胸膜炎和结核性淋巴结炎患者的治疗取得了成功，但血浆降钙素原水平持续升高。
Sci Rep. 2024 Sep 29;14(1):22590. doi: 10.1038/s41598-024-71627-5.
6
Rhabdomyolysis-related acute kidney injury in patients with COVID-19.新型冠状病毒肺炎患者横纹肌溶解相关急性肾损伤
World J Virol. 2024 Sep 25;13(3):91107. doi: 10.5501/wjv.v13.i3.91107.
7
A Retrospective Study: Evaluating the Impact of the COVID-19 Pandemic on Inflammatory Markers in Hospitalized Patients.一项回顾性研究：评估新冠疫情对住院患者炎症标志物的影响
Infect Dis Rep. 2024 Aug 14;16(4):735-749. doi: 10.3390/idr16040056.
8
Evolution of serious and life-threatening COVID-19 pneumonia as the SARS-CoV-2 pandemic progressed: an observational study of mortality to 60 days after admission to a 15-hospital US health system.严重和危及生命的 COVID-19 肺炎在 SARS-CoV-2 大流行期间的演变：对一家拥有 15 家医院的美国卫生系统住院后 60 天内死亡率的观察性研究。
BMJ Open. 2024 Jul 8;14(7):e075028. doi: 10.1136/bmjopen-2023-075028.
9
Nucleated red blood cells as a prognostic marker for mortality in patients with SARS-CoV-2-induced ARDS: an observational study.有核红细胞作为新型冠状病毒肺炎所致急性呼吸窘迫综合征患者死亡率的预后标志物：一项观察性研究
J Anesth Analg Crit Care. 2024 Jun 28;4(1):38. doi: 10.1186/s44158-024-00174-2.
10
Modulatory Roles of , , , and Gene Expression in Metabolic-Associated Fatty Liver Disease and COVID-19 Outcomes.基因表达在代谢相关脂肪性肝病和 COVID-19 结局中的调节作用。
Viruses. 2024 Jun 19;16(6):985. doi: 10.3390/v16060985.
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
4
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.中国武汉 140 名 SARS-CoV-2 感染患者的临床特征。
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.
5
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
6
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
7
Toward a holistic approach for diagnosing sepsis in the emergency department.急诊科诊断脓毒症的整体方法探讨。
Adv Clin Chem. 2019;92:201-216. doi: 10.1016/bs.acc.2019.04.004. Epub 2019 May 24.
8
Association of Procalcitonin Value and Bacterial Coinfections in Pediatric Patients With Viral Lower Respiratory Tract Infections Admitted to the Pediatric Intensive Care Unit.入住儿科重症监护病房的病毒性下呼吸道感染患儿降钙素原水平与细菌合并感染的相关性
J Pediatr Pharmacol Ther. 2018 Nov-Dec;23(6):466-472. doi: 10.5863/1551-6776-23.6.466.
9
Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future.降钙素原在感染诊断和抗生素决策指导中的作用：过去、现在和未来。
BMC Med. 2011 Sep 22;9:107. doi: 10.1186/1741-7015-9-107.
10
Measuring inconsistency in meta-analyses.评估荟萃分析中的异质性
BMJ. 2003 Sep 6;327(7414):557-60. doi: 10.1136/bmj.327.7414.557.